...investors. Separately,
Biogen Idec reported $1.1...was driven by Tysabri,
Biogen Idec's powerful drug to treat multiple sclerosis
and Crohn's disease. As...Corp. of Ireland. But
Biogen Idec chief executive...fifth since August. Todd
Wallack can be reached at twallack... (Page B5, 312 words)
By: Todd Wallack|Date: Feb 7, 2009